AI chatbot shows promise in depression treatment recommendations, study finds

Credit: Unsplash+

A recent study published in the journal Family Medicine and Community Health suggests that an AI language model, ChatGPT, may outperform primary care doctors in adhering to recognized treatment standards for clinical depression.

The research reveals that ChatGPT offers objective, data-driven insights, potentially serving as a valuable supplement to traditional diagnostic methods.

However, ethical issues, data privacy, and security concerns must be addressed, and AI should never replace human clinical judgment in depression diagnosis or treatment.

Depression Treatment Challenges

Depression is a widespread condition, and many affected individuals initially turn to primary care doctors for assistance.

Treatment recommendations should ideally align with evidence-based clinical guidelines and consider the severity of the depression.

However, treatment decisions often vary among physicians, and certain biases may influence recommendations.

Potential of ChatGPT

ChatGPT presents a promising solution in the field of depression treatment. It can offer rapid, objective insights based on data, ensuring confidentiality and anonymity for patients.

The study aimed to assess ChatGPT’s ability to evaluate recommended therapeutic approaches for mild and severe major depression and determine whether gender or social class biases influenced its recommendations compared to primary care doctors.

Research Methodology

The study used carefully designed vignettes centered around patients with symptoms of mild to moderate depression.

Eight versions of these vignettes included variations in patient characteristics, such as gender, social class, and depression severity.

Each vignette was evaluated by ChatGPT versions 3.5 and 4, and primary care doctors, with responses categorized into different treatment options.

Key Findings

In mild cases, ChatGPT consistently recommended referral for psychotherapy in line with clinical guidelines (95% for ChatGPT-3.5 and 97.5% for ChatGPT-4), while primary care doctors rarely did (just over 4%).

Primary care doctors often recommended drug treatment exclusively (48%) or a combination of psychotherapy and prescribed drugs (32.5%) for mild cases.

For severe cases, most doctors recommended a combination of psychotherapy and prescribed drugs (44.5%), whereas ChatGPT-3.5 (72%) and ChatGPT-4 (100%) aligned more closely with clinical guidelines.

ChatGPT showed no gender or social class biases in treatment recommendations, unlike previous research findings.

Ethical Concerns and Future Considerations

While ChatGPT demonstrates promise, ethical issues surrounding data privacy and security are paramount, given the sensitive nature of mental health data.

The study’s limitations include its focus on specific ChatGPT versions and data from French primary care doctors. The AI system’s recommendations should complement, not replace, human clinical judgment.


ChatGPT exhibits potential in enhancing decision-making for depression treatment in primary healthcare. Its objectivity and impartiality can benefit mental health services.

However, ongoing research is essential to validate the reliability of its suggestions. Ethical considerations must guide the implementation of AI systems to ensure data privacy, security, and the quality of mental health services.

If you care about depression, please read studies about vegetarianism linked to higher risk of depression, and Vitamin D could help reduce depression symptoms.

For more information about nutrition, please see recent studies that ultra-processed foods may make you feel depressed, and these antioxidants could help reduce the risk of dementia.

The research findings can be found in Family Medicine and Community Health.

Follow us on Twitter for more articles about this topic.

Copyright © 2023 Knowridge Science Report. All rights reserved.